A Prospective, Multi-Center, Non-Comparative Trial of the Clinical Safety of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology (ART) Procedures
Phase of Trial: Phase III
Latest Information Update: 03 Sep 2019
Price : $35 *
At a glance
- Drugs Progesterone (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms SARA
- Sponsors Ferring Pharmaceuticals
- 27 Aug 2019 Status changed from active, no longer recruiting to completed.
- 03 Apr 2019 Planned End Date changed from 15 Mar 2019 to 1 Aug 2019.
- 03 Apr 2019 Planned primary completion date changed from 1 Mar 2019 to 1 Aug 2019.